Ignite Creation Date:
2025-12-24 @ 5:32 PM
Ignite Modification Date:
2026-01-07 @ 6:56 AM
Study NCT ID:
NCT06523868
Status:
RECRUITING
Last Update Posted:
2025-04-10
First Post:
2024-07-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluation of Multi-Cancer Early Detection Testing in a High-Risk Military Population: The Sentinel Study
Sponsor:
Dana-Farber Cancer Institute
Organization:
Study Overview
Official Title:
Evaluation of Multi-Cancer Early Detection Testing in a High-Risk Military Population: The Sentinel Study
Status:
RECRUITING
Status Verified Date:
2025-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this research study is to evaluate the possible benefits of an investigational, but commercially available Galleri multi-cancer early detection (MCED) blood test which is designed to detect many types of cancer early in veterans who have served in the military in active duty.
The name of the screening blood test being studied is:
-GRAIL Galleri MCED test
The name of the screening blood test being studied is:
-GRAIL Galleri MCED test
Detailed Description:
This research study aims to assess the performance of the Galleri multi-cancer early detection (MCED) screening test in a military population and to compare the number and types of cancers diagnosed using MCED testing versus standard of care. This research study will give doctors and participants results of Galleri® blood tests which is designed to detect many types of cancer.
The research study procedures including screening for eligibility, blood draws, questionnaires, and clinic visits.
Participation in this research study is expected to last for up to 1 year.
It is expected that about 1,500 people will take part in this research study.
The Department of Defense (DoD) is funding this study.
The research study procedures including screening for eligibility, blood draws, questionnaires, and clinic visits.
Participation in this research study is expected to last for up to 1 year.
It is expected that about 1,500 people will take part in this research study.
The Department of Defense (DoD) is funding this study.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?: